Bruker's Division Rolls Out MyGenius PRO Diagnostics System in Europe

MT Newswires Live
04/17

Bruker's (BRKR) Bruker Microbiology & Infection Diagnostics division said Friday it has rolled out molecular diagnostics system MyGenius PRO in Europe.

The new diagnostics system is based on polymerase chain reaction, developed to diagnose infectious diseases, according to the division.

Bruker Microbiology said the MyGenius PRO system automates the complete workflow from patient sample to diagnostic result, adding it developed the system in partnership with ELITechGroup and Hitachi High Tech-Corp.

Additionally, Hitachi will launch the platform in Japan under the LABOSPECT GA-5 trade name, according to the company.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10